The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Astera Labs, Inc. | Common | 04626A103 | 134,835,252 | 2,573,683 | SH | DFND | 1 | 0 | 2,573,683 | 0 | |
| Joby Aviation Inc. | Common | G65163100 | 102,452,956 | 20,368,381 | SH | DFND | 1 | 0 | 20,368,381 | 0 | |
| Joby Aviation Inc. | Common | G65163100 | 14,272,092 | 2,837,394 | SH | DFND | 2 | 0 | 2,837,394 | 0 | |
| Senti Biosciences Inc | Common | 81726A100 | 108,588 | 48,048 | SH | DFND | 1 | 0 | 48,048 | 0 | |
